Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. To develop explicit, unambiguous, and transparent cli...
Uložené v:
| Vydané v: | Journal of allergy and clinical immunology Ročník 126; číslo 3; s. 466 - 476 |
|---|---|
| Hlavní autori: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
New York, NY
Elsevier Inc
01.09.2010
Elsevier Elsevier Limited |
| Predmet: | |
| ISSN: | 0091-6749, 1097-6825, 1097-6825 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally.
To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence.
The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group.
This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals.
These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. |
|---|---|
| AbstractList | Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally.
To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence.
The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group.
This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals.
These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. Background Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. Objective To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. Methods The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. Results This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. Conclusion These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. Background: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. Objective: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. Methods: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. Results: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. Conclusion: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally.BACKGROUNDAllergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally.To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence.OBJECTIVETo develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence.The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group.METHODSThe authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group.This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals.RESULTSThis article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals.These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions.CONCLUSIONThese are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. |
| Author | Baena-Cagnani, Carlos E. van Wijk, Roy Gerth Casale, Thomas B. Zuberbier, Torsten Brożek, Jan L. Canonica, G. Walter Schünemann, Holger J. Bonini, Sergio Ohta, Ken Bousquet, Jean |
| Author_xml | – sequence: 1 givenname: Jan L. surname: Brożek fullname: Brożek, Jan L. organization: Department of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada – sequence: 2 givenname: Jean surname: Bousquet fullname: Bousquet, Jean organization: Service des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Montpellier, France – sequence: 3 givenname: Carlos E. surname: Baena-Cagnani fullname: Baena-Cagnani, Carlos E. organization: Faculty of Medicine, Catholic University of Córdoba, Córdoba, Argentina – sequence: 4 givenname: Sergio surname: Bonini fullname: Bonini, Sergio organization: Institute of Neurobiology and Molecular Medicine—CNR, Rome, Italy – sequence: 5 givenname: G. Walter surname: Canonica fullname: Canonica, G. Walter organization: Allergy and Respiratory Diseases, DIMI, Department of Internal Medicine, University of Genoa, Genoa, Italy – sequence: 6 givenname: Thomas B. surname: Casale fullname: Casale, Thomas B. organization: Division of Allergy and Immunology, Department of Medicine, Creighton University, Omaha, Neb – sequence: 7 givenname: Roy Gerth surname: van Wijk fullname: van Wijk, Roy Gerth organization: Section of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands – sequence: 8 givenname: Ken surname: Ohta fullname: Ohta, Ken organization: Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan – sequence: 9 givenname: Torsten surname: Zuberbier fullname: Zuberbier, Torsten organization: Department of Dermatology and Allergy, Charité Universitätsmedizin, Berlin, Germany – sequence: 10 givenname: Holger J. surname: Schünemann fullname: Schünemann, Holger J. email: schuneh@mcmaster.ca organization: Department of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23238968$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20816182$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkltr3DAQhUVJaTZp_0AfiqGUtA_ejmzr4lAKJvSyNFDYts9ClseJXK-8lexA_n1kdkNgocmTkPjOEXPOnJAjNzgk5DWFJQXKP3bLThu7zCA-AF9CIZ6RBYVSpFxm7IgsAEqaclGUx-QkhA7iPZflC3KcgaScymxBflR9j_7KmmR9bZ0dbUi0axI7hmS12WozJoNLqjBeb3Tyvlqvqg_J1WQb7K3DcJ7MfydrvLHBDu4led7qPuCr_XlK_nz98vvie3r589vqorpMDadiTLmWRVPzkguEumgK2bSQi4LVBSuhbUFzY1BzxjLUKKTJa1oKjrnRILUs8_yUnO18t374N2EY1cYGg32vHQ5TUJIKDgVnT5OCFTFIkBDJtwdkN0zexTEUZcByAEazSL3ZU1O9wUZtvd1of6vu84zAuz2gg9F967UzNjxweRYL4DJycscZP4TgsVXGjnqMIY5e215RUHPFqlNzxWqOWQFXseIozQ6k9-6Pij7tRBh7ubHoVTAWncHGejSjagb7uPzzgdzEBbBxwr94i-EhKhUyBerXvHjz3lGIJkzMuZz_3-Cp3-8ATvDixA |
| CODEN | JACIBY |
| CitedBy_id | crossref_primary_10_1097_ACI_0000000000000150 crossref_primary_10_1136_archdischild_2013_304446 crossref_primary_10_1136_dtb_2018_000014 crossref_primary_10_1007_s11812_011_0010_2 crossref_primary_10_12968_hmed_2023_0212 crossref_primary_10_1016_j_jaci_2016_01_021 crossref_primary_10_1007_s40521_013_0005_6 crossref_primary_10_1111_all_13438 crossref_primary_10_1007_s15007_022_5060_5 crossref_primary_10_1016_j_jaci_2024_10_007 crossref_primary_10_3389_fphar_2022_935943 crossref_primary_10_1016_j_anai_2017_08_012 crossref_primary_10_1016_j_jaip_2023_05_022 crossref_primary_10_1016_j_amjcard_2012_08_027 crossref_primary_10_1016_j_ijporl_2017_04_006 crossref_primary_10_1016_j_jpeds_2018_06_053 crossref_primary_10_1111_j_1398_9995_2011_02682_x crossref_primary_10_1186_s13223_020_00468_4 crossref_primary_10_2196_45364 crossref_primary_10_1007_s11882_012_0331_y crossref_primary_10_1177_1945892420920499 crossref_primary_10_1016_j_jep_2018_11_037 crossref_primary_10_1111_all_12364 crossref_primary_10_1016_j_bjorl_2016_08_009 crossref_primary_10_1016_j_jaip_2021_02_035 crossref_primary_10_1155_2015_187620 crossref_primary_10_1111_all_12124 crossref_primary_10_1186_s13063_022_06020_6 crossref_primary_10_1016_j_imbio_2014_11_004 crossref_primary_10_1111_all_14786 crossref_primary_10_1007_s00405_019_05304_z crossref_primary_10_1073_pnas_1300512110 crossref_primary_10_1016_j_cegh_2019_12_018 crossref_primary_10_1016_j_bjorl_2024_101398 crossref_primary_10_1016_j_pharmthera_2022_108115 crossref_primary_10_1111_pai_13038 crossref_primary_10_1016_j_arbr_2013_03_004 crossref_primary_10_2500_ar_2014_5_0089 crossref_primary_10_1111_all_12370 crossref_primary_10_1159_000355953 crossref_primary_10_4168_aair_2020_12_2_238 crossref_primary_10_3109_07853890_2011_595426 crossref_primary_10_3109_02770903_2013_819105 crossref_primary_10_1016_j_jaip_2023_05_011 crossref_primary_10_2217_cpr_12_4 crossref_primary_10_1111_pai_12136 crossref_primary_10_1155_2016_5782317 crossref_primary_10_1016_j_jaci_2011_01_069 crossref_primary_10_1007_s12325_015_0192_6 crossref_primary_10_1111_all_12383 crossref_primary_10_1016_j_bjorl_2017_10_006 crossref_primary_10_1038_s41533_020_00195_8 crossref_primary_10_1007_s11726_016_0962_y crossref_primary_10_1186_s12950_024_00415_9 crossref_primary_10_1007_s40521_013_0007_4 crossref_primary_10_1186_s13052_018_0519_4 crossref_primary_10_1155_2020_7196981 crossref_primary_10_1017_S0022215114000450 crossref_primary_10_1017_S0022215114000693 crossref_primary_10_1111_pai_12126 crossref_primary_10_1016_j_intimp_2024_113644 crossref_primary_10_1016_j_anai_2015_05_017 crossref_primary_10_1016_j_anai_2020_08_005 crossref_primary_10_1016_j_jaci_2011_01_070 crossref_primary_10_1177_2152656718789519 crossref_primary_10_1185_03007995_2011_648263 crossref_primary_10_1016_j_jaci_2011_01_071 crossref_primary_10_1038_ejcn_2014_13 crossref_primary_10_11603_24116_4944_2025_1_15409 crossref_primary_10_2217_cpr_14_41 crossref_primary_10_1016_j_explore_2022_02_006 crossref_primary_10_1002_jcph_478 crossref_primary_10_1136_dtb_2014_2_0237 crossref_primary_10_1155_2018_9138904 crossref_primary_10_3109_13880209_2014_982299 crossref_primary_10_1373_jalm_2018_026526 crossref_primary_10_1016_j_jaci_2013_03_013 crossref_primary_10_1185_03007995_2012_672405 crossref_primary_10_1016_j_anai_2018_01_015 crossref_primary_10_1097_MOO_0b013e328347afd0 crossref_primary_10_1155_2020_5979708 crossref_primary_10_4168_aair_2018_10_4_370 crossref_primary_10_1007_s00011_012_0464_4 crossref_primary_10_35420_jcohns_2018_29_1_42 crossref_primary_10_1111_all_12164 crossref_primary_10_1186_s13223_023_00793_4 crossref_primary_10_1007_s11010_014_2142_z crossref_primary_10_1111_cea_14604 crossref_primary_10_1517_14728214_2016_1139082 crossref_primary_10_1159_000494507 crossref_primary_10_1016_j_phymed_2023_154948 crossref_primary_10_1016_j_jaip_2020_05_003 crossref_primary_10_1007_BF03262132 crossref_primary_10_1159_000488050 crossref_primary_10_1007_s00405_023_08078_7 crossref_primary_10_1177_1753465816669662 crossref_primary_10_1016_j_pepo_2012_07_008 crossref_primary_10_1177_1559325820904799 crossref_primary_10_1002_lary_23649 crossref_primary_10_5604_01_3001_0054_0941 crossref_primary_10_3402_acmo_v3_26601 crossref_primary_10_1016_j_heliyon_2021_e08556 crossref_primary_10_4168_aair_2017_9_2_116 crossref_primary_10_1111_j_1365_2222_2011_03929_x crossref_primary_10_1016_j_jaci_2019_01_053 crossref_primary_10_1016_j_reval_2014_12_007 crossref_primary_10_18311_jeoh_2024_36199 crossref_primary_10_1016_j_heliyon_2024_e39058 crossref_primary_10_1186_s13601_017_0159_6 crossref_primary_10_4168_aair_2015_7_2_158 crossref_primary_10_1016_j_anpede_2018_01_002 crossref_primary_10_3390_pharmacy8040183 crossref_primary_10_1016_j_waojou_2023_100849 crossref_primary_10_1080_02770903_2017_1326132 crossref_primary_10_47102_annals_acadmedsg_202076 crossref_primary_10_1016_j_anai_2024_10_019 crossref_primary_10_1111_cea_70137 crossref_primary_10_1177_1945892419883238 crossref_primary_10_1111_all_12988 crossref_primary_10_1016_j_anai_2014_08_015 crossref_primary_10_1016_j_bjorl_2017_01_002 crossref_primary_10_1080_03007995_2016_1240665 crossref_primary_10_1186_s12948_015_0029_5 crossref_primary_10_1038_s41598_024_54574_z crossref_primary_10_1007_s00112_016_0063_5 crossref_primary_10_1186_2045_7022_2_13 crossref_primary_10_1007_s11882_013_0341_4 crossref_primary_10_1186_2045_7022_2_16 crossref_primary_10_1183_13993003_00437_2018 crossref_primary_10_3109_02770903_2015_1056350 crossref_primary_10_1111_pai_12562 crossref_primary_10_3389_fphar_2024_1417013 crossref_primary_10_1007_s11882_014_0422_z crossref_primary_10_1016_j_arbres_2017_03_001 crossref_primary_10_36303_SAGP_0124 crossref_primary_10_1002_alr_22190 crossref_primary_10_4168_aair_2013_5_5_251 crossref_primary_10_2500_ajra_2012_26_3706 crossref_primary_10_1007_s40267_017_0381_2 crossref_primary_10_1159_000496938 crossref_primary_10_1177_00034894211008702 crossref_primary_10_1002_alr_22197 crossref_primary_10_1371_journal_pone_0090338 crossref_primary_10_3390_ijerph15071449 crossref_primary_10_1016_j_jaci_2020_07_007 crossref_primary_10_1186_s13063_019_3424_2 crossref_primary_10_1007_s11882_011_0185_8 crossref_primary_10_1186_s13223_018_0299_9 crossref_primary_10_1007_s00228_014_1767_x crossref_primary_10_1186_s13223_015_0083_z crossref_primary_10_1016_j_reval_2014_05_005 crossref_primary_10_1111_all_12760 crossref_primary_10_1186_1939_4551_7_6 crossref_primary_10_1016_j_jaci_2016_03_010 crossref_primary_10_1016_S1877_0320_11_70034_3 crossref_primary_10_1186_1939_4551_7_4 crossref_primary_10_1007_s40521_016_0076_2 crossref_primary_10_3389_fcimb_2023_1150043 crossref_primary_10_1142_S0192415X19500204 crossref_primary_10_1007_s11882_012_0288_x crossref_primary_10_1016_j_ctim_2022_102804 crossref_primary_10_1007_s11882_012_0242_y crossref_primary_10_1080_14656566_2024_2411009 crossref_primary_10_1016_j_jaci_2011_10_044 crossref_primary_10_1080_1744666X_2024_2373886 crossref_primary_10_25122_jml_2020_0015 crossref_primary_10_1111_fcp_12079 crossref_primary_10_4168_aair_2013_5_4_232 crossref_primary_10_1016_j_jaip_2017_05_028 crossref_primary_10_1177_00034894241304931 crossref_primary_10_1186_s13601_018_0227_6 crossref_primary_10_1186_s40413_015_0064_1 crossref_primary_10_1016_j_otc_2017_08_012 crossref_primary_10_1097_MOO_0000000000000045 crossref_primary_10_1016_j_jaci_2016_03_025 crossref_primary_10_1016_j_rmed_2018_01_020 crossref_primary_10_1002_clt2_12316 crossref_primary_10_1016_j_bjorl_2020_12_014 crossref_primary_10_1017_S0022215116000128 crossref_primary_10_1016_j_rmed_2015_05_010 crossref_primary_10_1111_all_12531 crossref_primary_10_1016_j_anai_2015_07_022 crossref_primary_10_1016_j_jaci_2013_05_032 crossref_primary_10_1016_j_anai_2020_06_032 crossref_primary_10_1007_s15007_019_1938_2 crossref_primary_10_1542_peds_2014_1641 crossref_primary_10_1007_s40267_016_0349_7 crossref_primary_10_1002_alr_23090 crossref_primary_10_1016_j_anai_2015_07_016 crossref_primary_10_1016_j_anl_2013_06_003 crossref_primary_10_1080_02770903_2017_1362428 crossref_primary_10_1016_j_waojou_2024_100926 crossref_primary_10_1002_alr_21905 crossref_primary_10_1007_s13318_025_00946_3 crossref_primary_10_1016_j_arbr_2018_12_020 crossref_primary_10_1136_bmjopen_2017_016326 crossref_primary_10_1096_fj_201902627R crossref_primary_10_1111_all_12782 crossref_primary_10_1111_resp_14174 crossref_primary_10_1136_archdischild_2014_306300 crossref_primary_10_1016_j_genhosppsych_2012_09_009 crossref_primary_10_1016_j_reval_2014_10_005 crossref_primary_10_1016_j_fsc_2011_10_006 crossref_primary_10_1177_03946320110240S406 crossref_primary_10_1111_j_1398_9995_2012_02822_x crossref_primary_10_1186_2045_7022_5_S4_P39 crossref_primary_10_1016_j_rmed_2018_03_014 crossref_primary_10_1097_WOX_0b013e3182784ee0 crossref_primary_10_2217_imt_2018_0051 crossref_primary_10_1016_j_reval_2014_10_003 crossref_primary_10_1007_s00405_017_4807_1 crossref_primary_10_1111_all_12791 crossref_primary_10_3390_pharmacy8020085 crossref_primary_10_1186_s13223_018_0268_3 crossref_primary_10_1016_j_wjorl_2020_12_001 crossref_primary_10_3109_00016489_2014_890739 crossref_primary_10_1111_all_13406 crossref_primary_10_1007_s10405_012_0584_0 crossref_primary_10_4168_aair_2015_7_1_83 crossref_primary_10_1186_s12890_021_01798_8 crossref_primary_10_1016_j_ctim_2019_102198 crossref_primary_10_1089_ped_2015_0519 crossref_primary_10_1111_cea_14212 crossref_primary_10_3109_02770903_2013_853082 crossref_primary_10_1007_s11010_017_2963_7 crossref_primary_10_3892_mmr_2016_6085 crossref_primary_10_4168_aair_2018_10_4_300 crossref_primary_10_1186_s12931_021_01766_0 crossref_primary_10_1586_1744666X_2015_1081814 crossref_primary_10_1007_s00060_017_5525_4 crossref_primary_10_1016_j_biopha_2018_11_073 crossref_primary_10_1002_clt2_12128 crossref_primary_10_1007_s12325_016_0347_0 crossref_primary_10_1016_j_molimm_2023_02_004 crossref_primary_10_1186_1471_2466_13_46 crossref_primary_10_2147_IJGM_S470949 crossref_primary_10_3892_etm_2017_4937 crossref_primary_10_1016_j_jaip_2020_08_025 crossref_primary_10_1111_j_1398_9995_2010_02530_x crossref_primary_10_1111_all_12573 crossref_primary_10_1097_GH9_0000000000000480 crossref_primary_10_1007_s00106_012_2484_3 crossref_primary_10_1080_1744666X_2016_1237288 crossref_primary_10_1111_all_13429 crossref_primary_10_1111_coa_12171 crossref_primary_10_1016_j_iac_2015_12_008 crossref_primary_10_1080_17460441_2017_1257115 crossref_primary_10_4103_pm_pm_461_19 crossref_primary_10_1016_j_iac_2015_12_004 crossref_primary_10_1016_j_reval_2012_01_034 crossref_primary_10_1016_j_iac_2015_12_001 crossref_primary_10_1007_s40267_016_0305_6 crossref_primary_10_1016_j_ijporl_2019_109759 crossref_primary_10_1517_14740338_2016_1112786 crossref_primary_10_1016_j_anl_2019_05_005 crossref_primary_10_1016_j_mayocp_2017_01_001 crossref_primary_10_5144_0256_4947_2013_469 crossref_primary_10_1007_s40521_016_0073_5 crossref_primary_10_3389_fphar_2024_1350063 crossref_primary_10_1007_s40521_021_00280_4 crossref_primary_10_1097_MD_0000000000015247 crossref_primary_10_1111_all_12903 crossref_primary_10_2500_ajra_2012_26_3785 crossref_primary_10_1177_1945892419865097 crossref_primary_10_1097_MD_0000000000029871 crossref_primary_10_1177_039463201102400212 crossref_primary_10_1007_s00405_015_3832_1 crossref_primary_10_1007_s00405_018_5123_0 crossref_primary_10_2500_ajra_2012_26_3787 crossref_primary_10_1080_13543784_2016_1192124 crossref_primary_10_1016_j_anorl_2017_06_005 crossref_primary_10_1097_01_NPR_0000444647_43315_8c crossref_primary_10_1517_17460441_2014_909403 crossref_primary_10_1016_j_iac_2011_02_004 crossref_primary_10_5662_wjm_v6_i4_200 crossref_primary_10_7759_cureus_40913 crossref_primary_10_1177_1945892419860646 crossref_primary_10_1007_s00106_012_2483_4 crossref_primary_10_4168_aair_2019_11_3_306 crossref_primary_10_1186_1745_9974_10_2 crossref_primary_10_1016_j_vaccine_2013_03_041 crossref_primary_10_1111_cea_14135 crossref_primary_10_1111_all_12917 crossref_primary_10_1002_alr_22118 crossref_primary_10_1186_s13223_017_0183_z crossref_primary_10_1016_j_aller_2014_04_011 crossref_primary_10_1016_j_eujim_2022_102166 crossref_primary_10_1002_alr_21294 crossref_primary_10_1177_0145561319874310 crossref_primary_10_1007_s00405_015_3769_4 crossref_primary_10_1007_s00405_020_05837_8 crossref_primary_10_3892_etm_2017_4215 crossref_primary_10_1177_1945892420964408 crossref_primary_10_1111_j_1365_2125_2012_04222_x crossref_primary_10_1007_s40521_018_0166_4 crossref_primary_10_1186_s13601_019_0252_0 crossref_primary_10_1016_j_aller_2019_06_013 crossref_primary_10_1371_journal_pone_0085802 crossref_primary_10_3389_falgy_2025_1600032 crossref_primary_10_1002_ppul_22912 crossref_primary_10_1111_pai_13717 crossref_primary_10_1016_j_aller_2019_06_011 crossref_primary_10_1016_j_jaip_2013_04_005 crossref_primary_10_2500_ajra_2012_26_3770 crossref_primary_10_1016_j_jaci_2015_04_047 crossref_primary_10_1089_tmj_2012_0020 crossref_primary_10_1016_j_ijthermalsci_2019_04_018 crossref_primary_10_1111_cea_13264 crossref_primary_10_1007_s15007_020_2551_0 crossref_primary_10_1016_j_ijporl_2013_07_019 crossref_primary_10_1155_2024_9692031 crossref_primary_10_1183_09031936_00014614 crossref_primary_10_1186_s13601_019_0243_1 crossref_primary_10_1097_DBP_0000000000001206 crossref_primary_10_3390_medsci6040114 crossref_primary_10_1016_j_anai_2011_07_014 crossref_primary_10_1002_alr_23259 crossref_primary_10_1007_s40629_017_0027_x crossref_primary_10_1007_s40136_013_0013_x crossref_primary_10_1016_j_intimp_2020_106603 crossref_primary_10_1016_j_jaip_2020_09_008 crossref_primary_10_1186_2046_4053_3_59 crossref_primary_10_1016_j_anorl_2017_07_003 crossref_primary_10_1164_rccm_202109_2205PP crossref_primary_10_1016_j_conctc_2016_06_002 crossref_primary_10_2500_ajra_2014_28_4112 crossref_primary_10_1371_journal_pone_0103540 crossref_primary_10_1016_j_jaip_2015_06_019 crossref_primary_10_1016_j_jaip_2016_11_024 crossref_primary_10_1016_j_phymed_2018_06_044 crossref_primary_10_1517_14740338_2013_788148 crossref_primary_10_7759_cureus_46663 crossref_primary_10_2500_aap_2022_43_210113 crossref_primary_10_1097_ACI_0000000000000513 crossref_primary_10_1111_all_13807 crossref_primary_10_1111_all_13805 crossref_primary_10_1016_j_molimm_2020_04_009 crossref_primary_10_1177_0194599812461999 crossref_primary_10_1007_s12070_020_02008_3 crossref_primary_10_1186_s13601_016_0116_9 crossref_primary_10_1177_1945892419826509 crossref_primary_10_1111_all_12963 crossref_primary_10_1039_D4FO01079E crossref_primary_10_1186_s40413_016_0133_0 crossref_primary_10_3389_fimmu_2021_723814 crossref_primary_10_1016_j_toxlet_2018_11_012 crossref_primary_10_1186_s13601_017_0150_2 crossref_primary_10_1186_s13223_017_0208_7 crossref_primary_10_1002_alr_22186 crossref_primary_10_1186_s43163_025_00845_z crossref_primary_10_1007_s40521_016_0105_1 crossref_primary_10_1016_j_arbres_2012_12_001 crossref_primary_10_1016_j_jaip_2013_03_012 crossref_primary_10_1186_s12955_020_01659_8 crossref_primary_10_1177_1945892420912370 crossref_primary_10_1186_s12887_025_05541_8 crossref_primary_10_2147_JAA_S281439 crossref_primary_10_1155_2014_746846 crossref_primary_10_1016_j_jaci_2012_07_053 crossref_primary_10_1111_coa_12695 crossref_primary_10_1016_j_heliyon_2024_e29450 crossref_primary_10_2165_11209310_000000000_00000 crossref_primary_10_1007_s00405_011_1916_0 crossref_primary_10_1155_2013_861213 crossref_primary_10_1186_s12955_017_0621_0 crossref_primary_10_1097_ACI_0b013e32834cb994 crossref_primary_10_1111_all_14240 crossref_primary_10_1016_j_jpsychores_2015_08_009 crossref_primary_10_1186_2045_7022_3_7 crossref_primary_10_1186_1741_7015_12_71 crossref_primary_10_1185_03007995_2015_1094653 crossref_primary_10_1016_j_bjorl_2015_01_003 crossref_primary_10_1186_1916_0216_42_58 crossref_primary_10_1517_14740338_2016_1122755 crossref_primary_10_1016_j_ijheh_2016_11_012 crossref_primary_10_25259_IJMS_192_2022 crossref_primary_10_1007_s40521_020_00245_z crossref_primary_10_2500_ajra_2017_31_4382 crossref_primary_10_1155_2020_6917185 crossref_primary_10_2500_ajra_2013_27_3856 crossref_primary_10_7705_biomedica_v38i3_3801 crossref_primary_10_3390_pharmaceutics15041195 crossref_primary_10_1111_all_13162 crossref_primary_10_1136_bmjopen_2014_006570 crossref_primary_10_1111_all_14013 crossref_primary_10_1186_s13601_015_0087_2 crossref_primary_10_1080_02770903_2021_1978480 crossref_primary_10_1016_j_waojou_2020_100106 crossref_primary_10_1183_13993003_02730_2021 crossref_primary_10_1159_000443273 crossref_primary_10_1016_j_biopha_2019_109675 crossref_primary_10_1155_2020_1847061 crossref_primary_10_1159_000512493 crossref_primary_10_3390_jpm13050835 crossref_primary_10_3390_medicina56090454 crossref_primary_10_1586_1744666X_2014_955476 crossref_primary_10_1177_20587392211016117 crossref_primary_10_3390_ijms21145010 crossref_primary_10_1002_alr_21695 crossref_primary_10_1016_j_reval_2019_06_006 crossref_primary_10_1186_s12889_024_18581_z crossref_primary_10_1080_07448481_2018_1462822 crossref_primary_10_2217_imt_11_171 crossref_primary_10_1371_journal_pone_0147778 crossref_primary_10_1016_j_ijpharm_2019_03_040 crossref_primary_10_1016_j_ijporl_2016_01_010 crossref_primary_10_1016_j_joim_2017_12_010 crossref_primary_10_1136_bmjopen_2017_019462 crossref_primary_10_1007_s40521_018_0162_8 crossref_primary_10_1016_j_drudis_2015_07_010 crossref_primary_10_1007_s40521_020_00243_1 crossref_primary_10_1016_j_nano_2013_05_011 crossref_primary_10_1177_1945892419875086 crossref_primary_10_1007_s00060_014_0263_3 crossref_primary_10_1007_s00405_014_3350_6 crossref_primary_10_1186_s12931_016_0430_8 crossref_primary_10_1186_s13223_018_0314_1 crossref_primary_10_1586_1744666X_2014_945434 crossref_primary_10_1016_j_jaip_2012_07_001 crossref_primary_10_1016_j_reval_2017_03_003 crossref_primary_10_1002_alr_21689 crossref_primary_10_1517_14656566_2014_872241 crossref_primary_10_1002_alr_21449 crossref_primary_10_2217_imt_2019_0187 crossref_primary_10_1016_j_arbres_2018_09_001 crossref_primary_10_3892_etm_2016_3616 crossref_primary_10_3390_jcm9051483 crossref_primary_10_1016_j_jaip_2018_01_028 crossref_primary_10_1002_alr_23414 crossref_primary_10_1371_journal_pone_0059174 crossref_primary_10_1097_MD_0000000000018554 crossref_primary_10_1007_s40136_017_0170_4 crossref_primary_10_1007_s40267_014_0165_x crossref_primary_10_1007_s11882_015_0570_9 crossref_primary_10_1016_j_anai_2015_10_025 crossref_primary_10_1016_j_reval_2019_07_007 crossref_primary_10_1111_j_1399_3038_2012_01323_x crossref_primary_10_1159_000506862 crossref_primary_10_1016_j_bjorl_2024_101424 crossref_primary_10_1007_s00005_017_0498_y crossref_primary_10_1155_2013_345217 crossref_primary_10_1016_j_intimp_2011_07_005 crossref_primary_10_1007_s15007_013_0351_5 crossref_primary_10_1155_2017_3054217 crossref_primary_10_2500_ajra_2013_27_3864 crossref_primary_10_3390_ijms20010213 crossref_primary_10_1016_j_cyto_2019_154880 crossref_primary_10_1016_j_ajo_2020_07_011 crossref_primary_10_2147_IJGM_S325969 crossref_primary_10_1007_s00405_011_1803_8 crossref_primary_10_1016_j_iac_2016_03_011 crossref_primary_10_1016_j_ebiom_2018_05_037 crossref_primary_10_3390_pathogens11010080 crossref_primary_10_1128_IAI_00934_17 crossref_primary_10_1007_s11596_014_1275_3 crossref_primary_10_1007_s40629_020_00133_7 crossref_primary_10_1007_s40629_022_00218_5 crossref_primary_10_1155_2016_7896081 crossref_primary_10_2147_JAA_S342495 crossref_primary_10_1017_S0022215121000967 crossref_primary_10_1111_cts_13455 crossref_primary_10_1038_s41572_020_00227_0 crossref_primary_10_1002_ohn_832 crossref_primary_10_1155_2020_2384596 crossref_primary_10_1016_j_alergo_2014_05_004 crossref_primary_10_1016_j_amjoto_2023_104135 crossref_primary_10_20538_1682_0363_2019_2_262_273 crossref_primary_10_1038_s41392_023_01344_4 crossref_primary_10_1089_acm_2016_0310 crossref_primary_10_1183_23120541_00015_2020 crossref_primary_10_1097_ACI_0000000000000375 crossref_primary_10_1371_journal_pone_0228533 crossref_primary_10_1186_s40413_016_0126_z crossref_primary_10_1016_j_waojou_2021_100612 crossref_primary_10_4168_aair_2017_9_3_220 crossref_primary_10_1016_j_pedneo_2017_11_020 crossref_primary_10_1016_j_lfs_2019_116901 crossref_primary_10_3390_healthcare13080875 crossref_primary_10_1080_02770903_2019_1684517 crossref_primary_10_1016_S1877_0320_20_30479_6 crossref_primary_10_3389_fncel_2016_00169 crossref_primary_10_1080_14656566_2018_1543401 crossref_primary_10_1111_all_13316 crossref_primary_10_1111_all_13317 crossref_primary_10_1136_bjsports_2011_090812 crossref_primary_10_1155_2014_326980 crossref_primary_10_6000_1927_5951_2016_06_03_3 crossref_primary_10_1186_s13601_016_0099_6 crossref_primary_10_1016_S2095_4964_17_60353_4 crossref_primary_10_1183_13993003_01023_2019 crossref_primary_10_1177_2473974X211052955 crossref_primary_10_1159_000442353 crossref_primary_10_1097_MD_0000000000008032 crossref_primary_10_3389_fgene_2022_899923 crossref_primary_10_2500_ajra_2017_31_4418 crossref_primary_10_1183_13993003_00385_2015 crossref_primary_10_1016_j_arbr_2017_03_026 crossref_primary_10_1016_j_cellimm_2019_104035 crossref_primary_10_1177_0394632015621769 crossref_primary_10_1097_ACI_0b013e3283445852 crossref_primary_10_3892_mmr_2017_6215 crossref_primary_10_1016_j_arbres_2021_10_003 crossref_primary_10_1016_j_jaip_2019_11_008 crossref_primary_10_36290_der_2019_004 crossref_primary_10_1186_s13601_015_0061_z crossref_primary_10_1016_j_reval_2024_104160 crossref_primary_10_1016_j_jaip_2014_01_009 crossref_primary_10_3389_fpubh_2024_1301095 crossref_primary_10_1007_s12070_014_0708_4 crossref_primary_10_1016_j_jaci_2012_01_047 crossref_primary_10_1111_all_14422 crossref_primary_10_1016_j_jaci_2017_03_050 crossref_primary_10_1007_s00405_016_3973_x crossref_primary_10_4168_aair_2024_16_1_9 crossref_primary_10_1111_all_12009 crossref_primary_10_1016_j_aller_2012_03_004 crossref_primary_10_1016_j_jclinepi_2015_12_008 crossref_primary_10_1016_j_aller_2012_03_005 crossref_primary_10_1002_alr_21615 crossref_primary_10_1016_j_jaip_2014_01_006 crossref_primary_10_1097_ACI_0000000000000043 crossref_primary_10_1097_ACI_0000000000000062 crossref_primary_10_3390_ijms19030673 crossref_primary_10_4103_0972_6691_124391 crossref_primary_10_1111_pai_12066 crossref_primary_10_1007_s15006_014_0004_y crossref_primary_10_1002_lary_26831 crossref_primary_10_1016_S1877_0320_11_70026_4 crossref_primary_10_1016_j_alergo_2017_02_003 crossref_primary_10_1016_j_alergo_2017_02_001 crossref_primary_10_1016_j_reval_2015_04_001 crossref_primary_10_1002_alr_21606 crossref_primary_10_3109_01480545_2012_682652 crossref_primary_10_3390_medicina54050083 crossref_primary_10_23736_S0022_4707_18_08556_0 crossref_primary_10_1513_AnnalsATS_201505_309ED crossref_primary_10_1007_s00106_021_01115_z crossref_primary_10_1016_j_iac_2011_05_002 crossref_primary_10_1186_s13601_019_0303_6 crossref_primary_10_4168_aair_2017_9_3_265 crossref_primary_10_1177_039463201202500313 crossref_primary_10_1038_s41533_018_0071_0 crossref_primary_10_1007_BF03262237 crossref_primary_10_1016_j_anai_2016_07_018 crossref_primary_10_1177_039463201202500318 crossref_primary_10_1007_s10735_013_9484_9 crossref_primary_10_2500_ajra_2011_25_3674 crossref_primary_10_1016_j_paed_2012_02_001 crossref_primary_10_1007_s40629_022_00241_6 crossref_primary_10_1517_14656566_2013_828693 crossref_primary_10_1016_j_jaci_2019_06_049 crossref_primary_10_1097_MD_0000000000022521 crossref_primary_10_1155_2019_6478102 crossref_primary_10_1016_j_reval_2018_10_006 crossref_primary_10_1111_pai_12260 crossref_primary_10_1097_MD_0000000000024943 crossref_primary_10_2147_JAA_S503477 crossref_primary_10_1016_j_iac_2011_05_009 crossref_primary_10_1155_2014_176597 crossref_primary_10_2217_imt_15_88 crossref_primary_10_1002_ebch_1865 crossref_primary_10_1111_pai_13332 crossref_primary_10_1155_2013_720879 crossref_primary_10_1111_all_13362 crossref_primary_10_3892_mmr_2018_9380 crossref_primary_10_1016_j_jconrel_2023_01_029 crossref_primary_10_1159_000499042 crossref_primary_10_2500_ajra_2015_29_4148 crossref_primary_10_1016_j_otc_2011_03_008 crossref_primary_10_1111_all_14215 crossref_primary_10_1111_cea_13884 crossref_primary_10_1155_2016_9471215 crossref_primary_10_1002_alr_21628 crossref_primary_10_1002_humu_23548 crossref_primary_10_1016_j_jaci_2014_06_034 crossref_primary_10_2196_63933 crossref_primary_10_1007_s40261_015_0267_9 crossref_primary_10_1186_s40733_015_0006_2 crossref_primary_10_1111_all_13370 crossref_primary_10_1111_all_12040 crossref_primary_10_1186_s13223_020_0416_4 crossref_primary_10_1016_j_alergo_2014_03_002 crossref_primary_10_1007_s00405_016_4128_9 crossref_primary_10_1186_s12890_016_0246_9 crossref_primary_10_1002_alr_22741 crossref_primary_10_1016_j_jamda_2015_12_017 crossref_primary_10_1002_alr_21654 crossref_primary_10_1016_j_otc_2011_03_001 crossref_primary_10_2217_imt_2022_0215 crossref_primary_10_1016_j_waojou_2021_100584 crossref_primary_10_1177_01945998211034724 crossref_primary_10_1002_alr_21657 crossref_primary_10_1056_NEJMcp1412282 crossref_primary_10_1016_j_alergo_2016_06_003 crossref_primary_10_1111_all_13141 crossref_primary_10_1183_13993003_01856_2015 crossref_primary_10_1159_000512561 crossref_primary_10_2500_ajra_2015_29_4164 crossref_primary_10_1080_03007995_2019_1681134 crossref_primary_10_1111_cea_12536 crossref_primary_10_1177_1945892420932768 crossref_primary_10_1186_s12948_017_0074_3 crossref_primary_10_1007_s11882_012_0330_z crossref_primary_10_3390_jcm10143183 crossref_primary_10_1177_00034894231176327 crossref_primary_10_29262_ram_v65i4_525 crossref_primary_10_1007_s12016_016_8542_y crossref_primary_10_4168_aair_2017_9_3_272 crossref_primary_10_2500_ajra_2015_29_4192 crossref_primary_10_3109_02770903_2015_1091005 crossref_primary_10_1186_1939_4551_6_5 crossref_primary_10_1007_s40521_016_0077_1 crossref_primary_10_1111_pai_12218 crossref_primary_10_1016_j_jaci_2017_05_040 crossref_primary_10_3892_etm_2012_798 crossref_primary_10_1080_03007995_2025_2452518 crossref_primary_10_1007_s11655_016_2453_x crossref_primary_10_1016_j_ufug_2018_04_001 crossref_primary_10_1186_s13223_017_0209_6 crossref_primary_10_1002_alr_22087 crossref_primary_10_1016_j_imr_2023_100973 crossref_primary_10_1002_gin2_12008 crossref_primary_10_1186_s12887_018_1019_9 crossref_primary_10_1002_alr_22073 crossref_primary_10_1111_jcmm_12014 crossref_primary_10_1371_journal_pone_0175452 crossref_primary_10_2500_ajra_2015_29_4189 crossref_primary_10_1111_cea_13207 crossref_primary_10_1111_j_1600_065X_2011_01029_x crossref_primary_10_1136_bmjopen_2018_026710 crossref_primary_10_1007_s00106_013_2709_0 crossref_primary_10_1111_cea_13686 crossref_primary_10_1136_bmjopen_2022_062435 crossref_primary_10_1055_a_1246_1288 crossref_primary_10_1007_s00405_018_5104_3 crossref_primary_10_1111_j_1398_9995_2011_02761_x crossref_primary_10_1016_j_aller_2016_09_001 crossref_primary_10_1186_s40733_015_0008_0 crossref_primary_10_1016_j_otc_2023_09_003 crossref_primary_10_1111_j_1365_2222_2011_03935_x crossref_primary_10_1097_MD_0000000000018931 crossref_primary_10_1016_j_jep_2022_115448 crossref_primary_10_1016_S1155_195X_12_57303_2 crossref_primary_10_1016_j_rmr_2013_08_006 crossref_primary_10_1016_j_clinthera_2017_10_006 crossref_primary_10_1016_j_pop_2016_04_006 crossref_primary_10_1159_000512920 crossref_primary_10_1097_MD_0000000000024121 crossref_primary_10_1038_ejcn_2012_197 crossref_primary_10_1080_14656566_2024_2307476 crossref_primary_10_1016_S1877_0320_11_70033_1 crossref_primary_10_1517_14656566_2011_600688 crossref_primary_10_1007_s40272_020_00419_x crossref_primary_10_1007_s40521_017_0110_z crossref_primary_10_1016_j_reval_2012_02_152 crossref_primary_10_2174_0113816128295952240306072100 crossref_primary_10_1038_s41598_020_79820_y crossref_primary_10_1111_pai_12653 crossref_primary_10_1016_j_eurger_2014_07_013 crossref_primary_10_1186_s13223_015_0109_6 crossref_primary_10_3390_ijerph17010298 crossref_primary_10_1007_s40521_016_0075_3 crossref_primary_10_1155_2020_2975974 crossref_primary_10_7326_ANNALS_24_00363 crossref_primary_10_1097_MD_0000000000010394 crossref_primary_10_1016_j_anai_2014_11_001 crossref_primary_10_1038_npjpcrm_2016_33 crossref_primary_10_1177_039463201402700405 crossref_primary_10_1007_s12070_018_1273_z crossref_primary_10_1097_MCP_0000000000000640 crossref_primary_10_1007_s11882_025_01195_9 crossref_primary_10_3390_nu13030934 crossref_primary_10_1016_j_jaip_2019_07_044 crossref_primary_10_1186_1477_7517_8_23 crossref_primary_10_1016_j_jaip_2019_06_003 crossref_primary_10_1016_j_jaip_2024_06_040 crossref_primary_10_3390_jcm8091338 crossref_primary_10_1016_j_anai_2019_05_020 crossref_primary_10_1093_qjmed_hcy259 crossref_primary_10_1016_j_otc_2023_08_009 crossref_primary_10_1186_s13020_019_0272_7 crossref_primary_10_1016_j_ijpharm_2019_118911 crossref_primary_10_1007_s00405_013_2875_4 crossref_primary_10_1097_ACI_0b013e32835c1b73 crossref_primary_10_1007_s00405_017_4785_3 crossref_primary_10_1080_07853890_2023_2287188 crossref_primary_10_1016_j_gene_2012_06_066 crossref_primary_10_1177_014556131809700803 crossref_primary_10_1002_clt2_12006 crossref_primary_10_1016_j_intimp_2017_04_005 crossref_primary_10_2500_ajra_2012_26_3836 crossref_primary_10_1586_17512433_2016_1148598 crossref_primary_10_1007_s00431_019_03444_2 crossref_primary_10_1111_all_12686 crossref_primary_10_3389_fmed_2021_731254 crossref_primary_10_1186_s13223_019_0368_8 crossref_primary_10_1111_cea_12386 crossref_primary_10_1111_cea_13234 crossref_primary_10_1016_j_rmr_2019_08_003 crossref_primary_10_1016_j_alergo_2016_04_002 crossref_primary_10_1155_2020_8363027 crossref_primary_10_1517_14656566_2015_1020789 crossref_primary_10_1177_1755738017719096 crossref_primary_10_1016_j_rmr_2024_07_005 crossref_primary_10_1111_all_12694 crossref_primary_10_1155_2020_9248479 crossref_primary_10_1586_1744666X_2013_828876 crossref_primary_10_1080_14740338_2016_1221399 crossref_primary_10_4168_aair_2023_15_6_725 crossref_primary_10_1111_coa_13143 crossref_primary_10_1155_2020_4176082 crossref_primary_10_1111_j_1399_3038_2012_01298_x crossref_primary_10_1002_ped4_12146 crossref_primary_10_1038_pr_2013_142 crossref_primary_10_1111_all_16387 crossref_primary_10_1183_16000617_0056_2018 crossref_primary_10_1016_j_intimp_2023_110623 crossref_primary_10_1111_resp_12116 crossref_primary_10_1080_1744666X_2016_1200467 crossref_primary_10_1016_j_jclinepi_2016_09_009 crossref_primary_10_1002_alr_23578 crossref_primary_10_20867_thm_15_1_1 crossref_primary_10_3109_02770903_2013_840789 crossref_primary_10_2147_JAA_S357288 crossref_primary_10_1016_j_anai_2019_08_010 crossref_primary_10_1007_s40267_013_0106_0 crossref_primary_10_1007_s12070_025_05793_x crossref_primary_10_32448_entupdates_459007 crossref_primary_10_1002_alr_21381 crossref_primary_10_1017_S0022215113000170 crossref_primary_10_1055_a_2194_6914 crossref_primary_10_1002_alr_21389 crossref_primary_10_1111_j_1399_3038_2011_01182_x crossref_primary_10_1002_alr_21141 crossref_primary_10_1016_j_aller_2015_05_004 crossref_primary_10_1016_j_bjorl_2024_101500 crossref_primary_10_1111_cea_13164 crossref_primary_10_1177_1945892418825094 crossref_primary_10_3389_fnut_2022_821900 crossref_primary_10_1016_j_bjorl_2015_11_009 crossref_primary_10_1002_jat_1726 crossref_primary_10_1186_s12944_023_01825_z crossref_primary_10_1186_s13601_016_0137_4 crossref_primary_10_2217_imt_2015_0017 crossref_primary_10_1186_s13020_025_01120_2 crossref_primary_10_2500_ajra_2016_30_4305 crossref_primary_10_1007_s40521_014_0013_1 crossref_primary_10_1177_1945892418764966 crossref_primary_10_1177_1945892418764964 crossref_primary_10_1007_s12070_018_1500_7 crossref_primary_10_1016_j_jaci_2016_06_060 crossref_primary_10_1038_npjpcrm_2015_82 crossref_primary_10_1016_j_jped_2020_08_005 crossref_primary_10_1111_ddg_12089 crossref_primary_10_1016_j_jaci_2016_05_029 crossref_primary_10_2147_JAA_S461295 crossref_primary_10_1186_2045_7022_4_15 crossref_primary_10_2217_imt_2019_0009 crossref_primary_10_1586_17476348_2015_1000866 crossref_primary_10_1007_s11882_018_0781_y crossref_primary_10_1111_j_1399_3038_2012_01322_x crossref_primary_10_1186_s12906_017_1988_5 crossref_primary_10_2500_ajra_2016_30_4316 crossref_primary_10_2217_imt_2015_0027 crossref_primary_10_1002_kjm2_12918 crossref_primary_10_1002_kjm2_12916 crossref_primary_10_1097_MD_0000000000020711 crossref_primary_10_1186_s12881_017_0379_6 crossref_primary_10_1111_j_1398_9995_2011_02590_x crossref_primary_10_1111_j_1472_9733_2011_01158_x crossref_primary_10_1016_j_rmed_2012_02_013 crossref_primary_10_5812_ijp_83995 crossref_primary_10_1016_j_aforl_2017_02_005 crossref_primary_10_1016_j_jaci_2016_06_059 crossref_primary_10_1007_s12603_016_0804_0 crossref_primary_10_1016_j_iac_2018_01_014 crossref_primary_10_1016_j_micpath_2021_105272 crossref_primary_10_1159_000450751 crossref_primary_10_1016_j_anai_2020_11_016 crossref_primary_10_1016_j_otc_2017_08_004 crossref_primary_10_1016_j_clim_2020_108383 crossref_primary_10_1016_j_aforl_2017_03_009 crossref_primary_10_1016_j_jaci_2020_07_036 crossref_primary_10_1515_jbcr_2016_0021 crossref_primary_10_1007_s15012_014_1745_0 crossref_primary_10_1155_2012_521780 crossref_primary_10_4102_safp_v65i1_5806 crossref_primary_10_2500_ajra_2013_27_3937 crossref_primary_10_4081_mrm_2021_775 crossref_primary_10_1111_pai_12926 crossref_primary_10_3109_02770903_2013_822081 crossref_primary_10_1002_lary_28433 crossref_primary_10_1016_j_jaci_2011_09_005 crossref_primary_10_1002_clt2_12185 crossref_primary_10_1007_s00106_011_2294_z crossref_primary_10_1007_s12070_021_02773_9 crossref_primary_10_1016_j_heliyon_2024_e32756 crossref_primary_10_4168_aair_2017_9_5_446 crossref_primary_10_1017_S0022215117001657 crossref_primary_10_1155_2015_214846 crossref_primary_10_1016_j_jconrel_2014_12_040 crossref_primary_10_1016_j_reval_2011_01_027 crossref_primary_10_1186_s12890_021_01410_z crossref_primary_10_1186_s13601_019_0242_2 crossref_primary_10_1016_j_jaci_2014_01_042 crossref_primary_10_1186_s13601_017_0173_8 crossref_primary_10_1002_clt2_70017 crossref_primary_10_1186_2045_7022_4_7 crossref_primary_10_1016_j_compbiomed_2023_107544 crossref_primary_10_1016_j_coi_2011_07_015 crossref_primary_10_1007_s10453_016_9469_8 crossref_primary_10_1159_000477727 crossref_primary_10_1186_s12889_024_20561_2 crossref_primary_10_1111_cea_13192 crossref_primary_10_1186_1710_1492_9_32 crossref_primary_10_2500_ajra_2016_30_4352 crossref_primary_10_1016_j_reval_2011_01_015 crossref_primary_10_1155_2020_6760436 crossref_primary_10_1186_s13223_016_0119_z crossref_primary_10_1007_s40136_013_0010_0 crossref_primary_10_1038_s41370_021_00304_w crossref_primary_10_2500_ajra_2014_28_4013 crossref_primary_10_1111_all_13701 crossref_primary_10_1586_eci_11_87 crossref_primary_10_1016_j_reprotox_2011_06_120 crossref_primary_10_1097_ACI_0000000000000414 crossref_primary_10_1186_s12948_018_0092_9 crossref_primary_10_1016_j_jaci_2013_08_029 crossref_primary_10_1080_1744666X_2022_2089654 crossref_primary_10_1016_j_rmed_2020_105949 crossref_primary_10_1016_j_jaci_2018_08_049 crossref_primary_10_1097_MD_0000000000020911 crossref_primary_10_1038_pr_2014_151 crossref_primary_10_1177_0009922814533590 crossref_primary_10_1016_j_jaip_2025_04_060 crossref_primary_10_2500_ajra_2013_27_3965 crossref_primary_10_1016_j_jaip_2020_05_020 crossref_primary_10_1016_j_ijporl_2015_02_002 crossref_primary_10_3389_fpubh_2021_749388 crossref_primary_10_2500_ajra_2013_27_3968 crossref_primary_10_4168_aair_2018_10_2_182 crossref_primary_10_29262_ram_v71i1_1263 crossref_primary_10_4103_pm_pm_513_20 crossref_primary_10_33590_emj_10314632 crossref_primary_10_1371_journal_pone_0283246 crossref_primary_10_2147_JAA_S374346 crossref_primary_10_1007_s40521_016_0092_2 crossref_primary_10_1586_1744666X_2015_1086645 crossref_primary_10_1183_13993003_01084_2015 crossref_primary_10_1586_1744666X_2016_1144473 crossref_primary_10_1080_02770903_2016_1247168 crossref_primary_10_1097_ACI_0b013e32834c2286 crossref_primary_10_2500_ajra_2014_28_4035 crossref_primary_10_1177_0300060518786905 crossref_primary_10_1016_j_jaci_2010_11_032 crossref_primary_10_1097_ACI_0b013e32835e8b94 crossref_primary_10_1016_j_ijporl_2018_12_019 crossref_primary_10_1016_j_imlet_2020_08_002 crossref_primary_10_1159_000358489 crossref_primary_10_1002_ppul_23264 crossref_primary_10_4168_aair_2019_11_5_655 crossref_primary_10_1016_j_ijheh_2015_12_001 crossref_primary_10_1080_00325481_2017_1333384 crossref_primary_10_2500_ajra_2013_27_3944 crossref_primary_10_1007_s40267_014_0131_7 crossref_primary_10_1111_ajo_12673 crossref_primary_10_1016_j_waojou_2020_100466 crossref_primary_10_12688_f1000research_15367_1 crossref_primary_10_2500_ajra_2014_28_4066 crossref_primary_10_2500_ajra_2013_27_3946 crossref_primary_10_1517_14728214_2012_746312 crossref_primary_10_1016_j_waojou_2020_100461 crossref_primary_10_1080_1744666X_2023_2214729 crossref_primary_10_3109_02770903_2015_1054403 crossref_primary_10_1517_14656566_2016_1145661 crossref_primary_10_1016_j_jaci_2010_11_049 crossref_primary_10_1016_j_aller_2015_03_001 crossref_primary_10_1097_ACI_0000000000000204 crossref_primary_10_1016_j_jaci_2017_01_049 crossref_primary_10_3389_fphar_2024_1340554 crossref_primary_10_1016_j_waojou_2025_101117 crossref_primary_10_1016_j_gene_2013_03_088 crossref_primary_10_2500_ajra_2016_30_4397 crossref_primary_10_1093_intimm_dxv055 crossref_primary_10_1186_s12889_023_16607_6 crossref_primary_10_2500_ajra_2013_27_3957 crossref_primary_10_1007_s15007_017_1433_6 crossref_primary_10_1016_j_anai_2016_12_011 crossref_primary_10_2196_16642 crossref_primary_10_5935_1808_8694_20130067 crossref_primary_10_1186_s13063_015_0707_0 crossref_primary_10_1177_0194599819832277 crossref_primary_10_1517_14740338_2011_604029 crossref_primary_10_1097_ACI_0b013e32834c229e crossref_primary_10_1007_s00106_013_2700_9 crossref_primary_10_1007_s15007_013_0065_8 crossref_primary_10_1097_ACI_0000000000000456 crossref_primary_10_1186_s13601_019_0279_2 crossref_primary_10_3390_ijerph17218207 crossref_primary_10_1016_j_cyto_2022_156027 crossref_primary_10_1016_j_jclinepi_2015_11_017 crossref_primary_10_2500_ar_2016_7_0176 crossref_primary_10_1186_s13063_018_3151_0 crossref_primary_10_1007_s40629_019_00110_9 crossref_primary_10_1186_1465_9921_13_50 crossref_primary_10_1097_ACI_0b013e3283457ab0 crossref_primary_10_1016_j_jaip_2021_10_001 crossref_primary_10_1186_2049_6958_7_49 crossref_primary_10_1177_0003489418812902 crossref_primary_10_1016_j_ijporl_2017_04_040 crossref_primary_10_1016_j_pop_2013_10_005 crossref_primary_10_1186_s13223_021_00614_6 crossref_primary_10_2500_ar_2016_7_0186 crossref_primary_10_1016_j_jaci_2013_09_004 crossref_primary_10_1016_j_jaip_2014_02_001 crossref_primary_10_2217_imt_2019_0051 crossref_primary_10_2500_ar_2016_7_0185 crossref_primary_10_1002_lio2_645 crossref_primary_10_1016_j_imbio_2012_11_006 crossref_primary_10_3109_02770903_2011_604886 crossref_primary_10_1002_alr_23521 crossref_primary_10_1007_s11356_020_08709_0 crossref_primary_10_1007_s11356_022_19897_2 crossref_primary_10_1080_14712598_2025_2531035 crossref_primary_10_1136_dtb_2013_1_0166 crossref_primary_10_1007_s40267_015_0254_5 crossref_primary_10_1016_j_joim_2021_01_012 crossref_primary_10_1016_j_reval_2013_07_003 crossref_primary_10_1016_j_zefq_2019_06_001 crossref_primary_10_1136_acupmed_2016_011354 crossref_primary_10_1089_ped_2014_0344 crossref_primary_10_1016_j_aller_2018_01_001 crossref_primary_10_1080_00325481_2015_1016386 crossref_primary_10_1080_24745332_2017_1410456 crossref_primary_10_1016_j_anai_2023_07_019 crossref_primary_10_1016_j_iac_2014_09_003 crossref_primary_10_1111_all_13098 crossref_primary_10_1097_01_NPR_0000406485_59758_a8 crossref_primary_10_1111_j_1398_9995_2012_02861_x crossref_primary_10_1002_alr_21370 crossref_primary_10_1186_s12948_021_00158_5 crossref_primary_10_1097_MD_0000000000011812 crossref_primary_10_1038_s41598_023_46869_4 crossref_primary_10_1016_j_jaci_2014_03_019 crossref_primary_10_1016_j_cyto_2019_02_008 crossref_primary_10_1186_s12948_015_0023_y crossref_primary_10_3390_ph18030326 crossref_primary_10_1016_j_jaci_2012_01_077 crossref_primary_10_1016_j_jaip_2022_07_020 crossref_primary_10_1016_S1877_0320_11_70028_8 crossref_primary_10_1007_s40521_014_0042_9 crossref_primary_10_1111_cea_12938 crossref_primary_10_1016_j_jaci_2010_11_018 crossref_primary_10_1007_s15007_022_5665_8 crossref_primary_10_1016_j_anpedi_2017_10_014 crossref_primary_10_1016_j_intimp_2013_02_009 crossref_primary_10_2500_ajra_2017_31_4434 crossref_primary_10_1016_j_otpol_2013_12_003 crossref_primary_10_1002_alr_22217 crossref_primary_10_1097_ACI_0000000000000495 crossref_primary_10_1002_alr_22219 crossref_primary_10_1155_2012_212867 |
| Cites_doi | 10.1111/j.1398-9995.2007.01620.x 10.1034/j.1398-9995.2003.00076.x 10.1067/mai.2001.118891 10.1111/j.1398-9995.2008.01642.x 10.1164/rccm.200602-197ST 10.4104/pcrj.2009.00028 10.1136/bmj.39490.551019.BE 10.1136/bmj.39489.470347.AD 10.1016/j.jaci.2008.06.003 10.1186/1478-4505-4-19 10.1111/j.1398-9995.2007.01560.x 10.1016/S0140-6736(09)60787-X 10.1111/j.1398-9995.2008.01884.x 10.1111/j.1365-2222.2007.02888.x 10.1186/1478-4505-4-28 10.1111/j.1398-9995.2006.01144.x 10.1016/j.pcrj.2005.11.002 10.1136/bmj.39493.646875.AE 10.1111/j.1398-9995.2009.01973.x 10.1111/j.1398-9995.2003.00468.x 10.1111/j.1398-9995.2009.02325.x |
| ContentType | Journal Article |
| Contributor | Dykewicz, M S Bateman, E Denburg, J Chavannes, N H Costa, D J Pawankar, R Yusuf, O Demoly, P Marshall, G Nelson, H S Vandenplas, O Lee, B W Bousquet, P J Potter, P Rabe, K Boulet, L P Rosenwasser, L Toskala, E El Gamal, Y Mullol, J Fokkens, W J Kuna, P Cruz, A De Blay, F Camargos, P Larenas, D Baker, A Price, D Ameille, J Ben Kheder, A Okamoto, Y Ryan, D Yawn, B Bachert, C Chuchalin, A Le, L Yorgancioglu, A Bush, A Cox, L Dahl, R Cazzola, M Li, J Wickman, M Ivancevic, J C Valiulis, A Douagui, H Kaliner, M Kalayci, O Martinez, F D Custovic, A Humbert, M Chan, Yeung M Niggemann, B Shaik, A Simons, F E R Bouchard, J Agache, I Valovirta, E Zitt, M Papadopoulos, N Holgate, S Fukuda, T Lockey, R Malling, H Y Mohammad, Y Scadding, G Kim, Y Y Park, H S Van Weel, C Chen, Y C O'Hehir, R Sanchez Borges, M Calderon, M Dokic, D Wang, D Y Lipworth, B Carlsen, K H Rodríguez-Pérez, N |
| Contributor_xml | – sequence: 1 givenname: I surname: Agache fullname: Agache, I – sequence: 2 givenname: J surname: Ameille fullname: Ameille, J – sequence: 3 givenname: C surname: Bachert fullname: Bachert, C – sequence: 4 givenname: A surname: Baker fullname: Baker, A – sequence: 5 givenname: E surname: Bateman fullname: Bateman, E – sequence: 6 givenname: A surname: Ben Kheder fullname: Ben Kheder, A – sequence: 7 givenname: J surname: Bouchard fullname: Bouchard, J – sequence: 8 givenname: L P surname: Boulet fullname: Boulet, L P – sequence: 9 givenname: P J surname: Bousquet fullname: Bousquet, P J – sequence: 10 givenname: A surname: Bush fullname: Bush, A – sequence: 11 givenname: M surname: Calderon fullname: Calderon, M – sequence: 12 givenname: P surname: Camargos fullname: Camargos, P – sequence: 13 givenname: K H surname: Carlsen fullname: Carlsen, K H – sequence: 14 givenname: M surname: Cazzola fullname: Cazzola, M – sequence: 15 givenname: Yeung M surname: Chan fullname: Chan, Yeung M – sequence: 16 givenname: N H surname: Chavannes fullname: Chavannes, N H – sequence: 17 givenname: Y C surname: Chen fullname: Chen, Y C – sequence: 18 givenname: A surname: Chuchalin fullname: Chuchalin, A – sequence: 19 givenname: D J surname: Costa fullname: Costa, D J – sequence: 20 givenname: L surname: Cox fullname: Cox, L – sequence: 21 givenname: A surname: Cruz fullname: Cruz, A – sequence: 22 givenname: A surname: Custovic fullname: Custovic, A – sequence: 23 givenname: R surname: Dahl fullname: Dahl, R – sequence: 24 givenname: F surname: De Blay fullname: De Blay, F – sequence: 25 givenname: P surname: Demoly fullname: Demoly, P – sequence: 26 givenname: J surname: Denburg fullname: Denburg, J – sequence: 27 givenname: D surname: Dokic fullname: Dokic, D – sequence: 28 givenname: H surname: Douagui fullname: Douagui, H – sequence: 29 givenname: M S surname: Dykewicz fullname: Dykewicz, M S – sequence: 30 givenname: Y surname: El Gamal fullname: El Gamal, Y – sequence: 31 givenname: W J surname: Fokkens fullname: Fokkens, W J – sequence: 32 givenname: T surname: Fukuda fullname: Fukuda, T – sequence: 33 givenname: S surname: Holgate fullname: Holgate, S – sequence: 34 givenname: M surname: Humbert fullname: Humbert, M – sequence: 35 givenname: J C surname: Ivancevic fullname: Ivancevic, J C – sequence: 36 givenname: O surname: Kalayci fullname: Kalayci, O – sequence: 37 givenname: M surname: Kaliner fullname: Kaliner, M – sequence: 38 givenname: Y Y surname: Kim fullname: Kim, Y Y – sequence: 39 givenname: P surname: Kuna fullname: Kuna, P – sequence: 40 givenname: D surname: Larenas fullname: Larenas, D – sequence: 41 givenname: L surname: Le fullname: Le, L – sequence: 42 givenname: B W surname: Lee fullname: Lee, B W – sequence: 43 givenname: J surname: Li fullname: Li, J – sequence: 44 givenname: B surname: Lipworth fullname: Lipworth, B – sequence: 45 givenname: R surname: Lockey fullname: Lockey, R – sequence: 46 givenname: H Y surname: Malling fullname: Malling, H Y – sequence: 47 givenname: G surname: Marshall fullname: Marshall, G – sequence: 48 givenname: F D surname: Martinez fullname: Martinez, F D – sequence: 49 givenname: Y surname: Mohammad fullname: Mohammad, Y – sequence: 50 givenname: J surname: Mullol fullname: Mullol, J – sequence: 51 givenname: H S surname: Nelson fullname: Nelson, H S – sequence: 52 givenname: B surname: Niggemann fullname: Niggemann, B – sequence: 53 givenname: R surname: O'Hehir fullname: O'Hehir, R – sequence: 54 givenname: Y surname: Okamoto fullname: Okamoto, Y – sequence: 55 givenname: N surname: Papadopoulos fullname: Papadopoulos, N – sequence: 56 givenname: H S surname: Park fullname: Park, H S – sequence: 57 givenname: R surname: Pawankar fullname: Pawankar, R – sequence: 58 givenname: P surname: Potter fullname: Potter, P – sequence: 59 givenname: D surname: Price fullname: Price, D – sequence: 60 givenname: K surname: Rabe fullname: Rabe, K – sequence: 61 givenname: N surname: Rodríguez-Pérez fullname: Rodríguez-Pérez, N – sequence: 62 givenname: L surname: Rosenwasser fullname: Rosenwasser, L – sequence: 63 givenname: D surname: Ryan fullname: Ryan, D – sequence: 64 givenname: M surname: Sanchez Borges fullname: Sanchez Borges, M – sequence: 65 givenname: G surname: Scadding fullname: Scadding, G – sequence: 66 givenname: A surname: Shaik fullname: Shaik, A – sequence: 67 givenname: F E R surname: Simons fullname: Simons, F E R – sequence: 68 givenname: E surname: Toskala fullname: Toskala, E – sequence: 69 givenname: A surname: Valiulis fullname: Valiulis, A – sequence: 70 givenname: E surname: Valovirta fullname: Valovirta, E – sequence: 71 givenname: C surname: Van Weel fullname: Van Weel, C – sequence: 72 givenname: O surname: Vandenplas fullname: Vandenplas, O – sequence: 73 givenname: D Y surname: Wang fullname: Wang, D Y – sequence: 74 givenname: M surname: Wickman fullname: Wickman, M – sequence: 75 givenname: B surname: Yawn fullname: Yawn, B – sequence: 76 givenname: A surname: Yorgancioglu fullname: Yorgancioglu, A – sequence: 77 givenname: O surname: Yusuf fullname: Yusuf, O – sequence: 78 givenname: M surname: Zitt fullname: Zitt, M |
| Copyright | 2010 American Academy of Allergy, Asthma & Immunology American Academy of Allergy, Asthma & Immunology 2015 INIST-CNRS Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. Copyright Elsevier Limited Sep 2010 |
| Copyright_xml | – notice: 2010 American Academy of Allergy, Asthma & Immunology – notice: American Academy of Allergy, Asthma & Immunology – notice: 2015 INIST-CNRS – notice: Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. – notice: Copyright Elsevier Limited Sep 2010 |
| CorporateAuthor | Grading of Recommendations Assessment, Development and Evaluation Working Group Global Allergy and Asthma European Network |
| CorporateAuthor_xml | – name: Global Allergy and Asthma European Network – name: Grading of Recommendations Assessment, Development and Evaluation Working Group |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 |
| DOI | 10.1016/j.jaci.2010.06.047 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Nursing and Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE Entomology Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6825 |
| EndPage | 476 |
| ExternalDocumentID | 3241196771 20816182 23238968 10_1016_j_jaci_2010_06_047 S0091674910010572 1_s2_0_S0091674910010572 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Practice Guideline |
| GeographicLocations | Ontario Canada Netherlands Manitoba Canada Belgium United Kingdom--UK Japan China Denmark Brazil Italy South Africa France |
| GeographicLocations_xml | – name: South Africa – name: Ontario Canada – name: Netherlands – name: United Kingdom--UK – name: Japan – name: Italy – name: Denmark – name: China – name: Manitoba Canada – name: Belgium – name: France – name: Brazil |
| GrantInformation_xml | – fundername: Ansell, Bayer Schering, DST, Fujisawa, HAL, Henkel, Kryolan, Leti, Merck Sharp & Dohme, Novartis, Procter & Gamble, Sanofi-Aventis, Schering Plough, Stallergenes and UCB Pharma – fundername: Allmiral, ALK, AstraZeneca, Chiesi Farmaceutici, Faes Pharma, GlaxoSmithKline, Meda, Merck Sharp and Dohme, Mundifarma, Novartis, Nycomed-Altana, Roche, Sanofi-Aventis, Stallergènes, Schering- Plough, Teva, UCB and Uriach – fundername: Allergopharma, Allmiral, Alcon, Crucell, Hal, Merck Sharp & Dome, Novartis, Stallargènes and UCB – fundername: Abello, ALK, FAES (Spain), GlaxoSmithKline, Grünenthal (Venezuela), Lofarma (Italy), Merk Serono, MSD, Novartis, Phoenix (Argentina), Sanofi-Aventis, Schering-Plough, and Uriach (Spain) – fundername: AstraZeneca, GlaxoSmithKline, Merck Banyu, Novartis, Schering Plough, Kyorin, Otsuka, and Taisho – fundername: European Commission Framework Programme grantid: FOOD-CT-2004-506378 – fundername: Boehringer Ingelheim – fundername: ALK, Almirall, AstraZeneca, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Novartis, Nycomed, Phadia, Schering-Plough, Sigma Tau and Stallergens – fundername: A. Menarini, Alcon, Alk-Abellò, Almirall, Anallergo, AstraZeneca, Biofutura Pharma, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Lofarma, Merck Sharp & Dome, Novartis, Nycomed, Pfizer, Phadia, Schering Plough, SigmaTau, Stallergenes, UCB Pharma, Uriach and Valeas – fundername: GlaxoSmithKline and i3 Research – fundername: Medical Research Council grantid: G0800766 – fundername: Medical Research Council grantid: G19/34 |
| GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~HD ~KM AACTN RIG 9DU AAYXX CITATION AGCQF AGRNS IQODW CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c617t-6a84db6967e0b4d48df03745b4590ff0a6ccea6552eae78c3b1976e3ca08a8933 |
| ISICitedReferencesCount | 1208 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000281512500008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0091-6749 1097-6825 |
| IngestDate | Sun Sep 28 07:06:36 EDT 2025 Wed Oct 01 17:04:11 EDT 2025 Tue Oct 07 06:18:01 EDT 2025 Mon Jul 21 06:01:16 EDT 2025 Mon Jul 21 09:15:08 EDT 2025 Tue Nov 18 22:19:08 EST 2025 Sat Nov 29 07:25:09 EST 2025 Sun Apr 06 06:54:18 EDT 2025 Wed Apr 02 07:27:49 EDT 2025 Tue Oct 14 19:30:21 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | AR GRADE practice guideline ARIA Allergic Rhinitis and its Impact on Asthma Grading of Recommendations Assessment, Development and Evaluation Allergic rhinitis Lung disease Allergy Immunopathology Nose disease Rhinitis Respiratory disease Recommendation Asthma Immunology Revision Professional practice ENT disease Bronchus disease Obstructive pulmonary disease |
| Language | English |
| License | CC BY 4.0 Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c617t-6a84db6967e0b4d48df03745b4590ff0a6ccea6552eae78c3b1976e3ca08a8933 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 20816182 |
| PQID | 1505300512 |
| PQPubID | 105664 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_817604653 proquest_miscellaneous_754016080 proquest_journals_1505300512 pubmed_primary_20816182 pascalfrancis_primary_23238968 crossref_citationtrail_10_1016_j_jaci_2010_06_047 crossref_primary_10_1016_j_jaci_2010_06_047 elsevier_sciencedirect_doi_10_1016_j_jaci_2010_06_047 elsevier_clinicalkeyesjournals_1_s2_0_S0091674910010572 elsevier_clinicalkey_doi_10_1016_j_jaci_2010_06_047 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-09-01 |
| PublicationDateYYYYMMDD | 2010-09-01 |
| PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States – name: St. Louis |
| PublicationTitle | Journal of allergy and clinical immunology |
| PublicationTitleAlternate | J Allergy Clin Immunol |
| PublicationYear | 2010 |
| Publisher | Elsevier Inc Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
| References | Wallace, Dykewicz, Bernstein, Blessing-Moore, Cox, Khan (bib7) 2008; 122 Brozek, Baena-Cagnani, Bonini, Canonica, Rasi, van Wijk (bib9) 2008; 63 Costa, Bousquet, Ryan, Price, Demoly, Brozek (bib13) 2009; 18 Bousquet, Lund, Van Cauwenberge, Bremard-Oury, Mounedji, Stevens (bib3) 2003; 58 Brozek, Akl, Alonso-Coello, Lang, Jaeschke, Williams (bib17) 2009; 64 Guyatt, Oxman, Kunz, Vist, Falck-Ytter, Schunemann (bib15) 2008; 336 Church, Maurer, Simons, Bindslev-Jensen, van Cauwenberge, Bousquet (bib20) 2010; 65 Price, Bond, Bouchard, Costa, Keenan, Levy (bib5) 2006; 15 Schünemann, Jaeschke, Cook, Bria, El-Solh, Ernst (bib8) 2006; 174 Oxman, Schunemann, Fretheim (bib11) 2006; 4 Bousquet, van Cauwenberge, Ait Khaled, Bachert, Baena-Cagnani, Bouchard (bib21) 2006; 61 Ait-Khaled, Pearce, Anderson, Ellwood, Montefort, Shah (bib2) 2009; 64 (bib18) 2004; 59 Scadding, Durham, Mirakian, Jones, Leech, Farooque (bib6) 2008; 38 Guyatt, Oxman, Vist, Kunz, Falck-Ytter, Alonso-Coello (bib16) 2008; 336 Bousquet, Reid, van Weel, Baena Cagnani, Canonica, Demoly (bib19) 2008; 63 Bousquet, Van Cauwenberge, Khaltaev (bib4) 2001; 108 Hirsh, Guyatt (bib12) 2009; 374 Oxman, Schunemann, Fretheim (bib10) 2006; 4 Guyatt, Oxman, Kunz, Falck-Ytter, Vist, Liberati (bib14) 2008; 336 Bousquet, Khaltaev, Cruz, Denburg, Fokkens, Togias (bib1) 2008; 63 Schünemann (10.1016/j.jaci.2010.06.047_bib8) 2006; 174 Ait-Khaled (10.1016/j.jaci.2010.06.047_bib2) 2009; 64 Bousquet (10.1016/j.jaci.2010.06.047_bib4) 2001; 108 Hirsh (10.1016/j.jaci.2010.06.047_bib12) 2009; 374 Bousquet (10.1016/j.jaci.2010.06.047_bib3) 2003; 58 Oxman (10.1016/j.jaci.2010.06.047_bib11) 2006; 4 Scadding (10.1016/j.jaci.2010.06.047_bib6) 2008; 38 Bousquet (10.1016/j.jaci.2010.06.047_bib19) 2008; 63 Bousquet (10.1016/j.jaci.2010.06.047_bib21) 2006; 61 Guyatt (10.1016/j.jaci.2010.06.047_bib14) 2008; 336 Guyatt (10.1016/j.jaci.2010.06.047_bib16) 2008; 336 (10.1016/j.jaci.2010.06.047_bib18) 2004; 59 Price (10.1016/j.jaci.2010.06.047_bib5) 2006; 15 Costa (10.1016/j.jaci.2010.06.047_bib13) 2009; 18 Wallace (10.1016/j.jaci.2010.06.047_bib7) 2008; 122 Guyatt (10.1016/j.jaci.2010.06.047_bib15) 2008; 336 Brozek (10.1016/j.jaci.2010.06.047_bib9) 2008; 63 Church (10.1016/j.jaci.2010.06.047_bib20) 2010; 65 Bousquet (10.1016/j.jaci.2010.06.047_bib1) 2008; 63 Brozek (10.1016/j.jaci.2010.06.047_bib17) 2009; 64 Oxman (10.1016/j.jaci.2010.06.047_bib10) 2006; 4 21496893 - J Allergy Clin Immunol. 2011 Jun;127(6):1641-2; author reply 1643-5. doi: 10.1016/j.jaci.2011.01.071. 21481444 - J Allergy Clin Immunol. 2011 Jun;127(6):1640-1.e1; author reply 1643-5. doi: 10.1016/j.jaci.2011.01.070. |
| References_xml | – volume: 4 start-page: 19 year: 2006 ident: bib11 article-title: Improving the use of research evidence in guideline development: 7. Deciding what evidence to include publication-title: Health Res Policy Syst – volume: 336 start-page: 995 year: 2008 end-page: 998 ident: bib15 article-title: What is “quality of evidence” and why is it important to clinicians? publication-title: BMJ – volume: 174 start-page: 605 year: 2006 end-page: 614 ident: bib8 article-title: An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations publication-title: Am J Respir Crit Care Med – volume: 64 start-page: 669 year: 2009 end-page: 677 ident: bib17 article-title: Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions publication-title: Allergy – volume: 108 start-page: S147 year: 2001 end-page: S334 ident: bib4 article-title: Allergic rhinitis and its impact on asthma publication-title: J Allergy Clin Immunol – volume: 4 start-page: 28 year: 2006 ident: bib10 article-title: Improving the use of research evidence in guideline development: 16 publication-title: Evaluation. Health Res Policy Syst – volume: 65 start-page: 459 year: 2010 end-page: 466 ident: bib20 article-title: Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper publication-title: Allergy – volume: 336 start-page: 924 year: 2008 end-page: 926 ident: bib16 article-title: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations publication-title: BMJ – volume: 64 start-page: 123 year: 2009 end-page: 148 ident: bib2 article-title: Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three publication-title: Allergy – volume: 59 start-page: 373 year: 2004 end-page: 387 ident: bib18 article-title: ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma publication-title: Allergy – volume: 61 start-page: 1086 year: 2006 end-page: 1096 ident: bib21 article-title: Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN) publication-title: Allergy – volume: 122 start-page: S1 year: 2008 end-page: S84 ident: bib7 article-title: The diagnosis and management of rhinitis: an updated practice parameter publication-title: J Allergy Clin Immunol – volume: 63 start-page: 38 year: 2008 end-page: 46 ident: bib9 article-title: Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update publication-title: Allergy – volume: 18 start-page: 250 year: 2009 end-page: 257 ident: bib13 article-title: Guidelines for allergic rhinitis need to be used in primary care publication-title: Prim Care Respir J – volume: 336 start-page: 1049 year: 2008 end-page: 1051 ident: bib14 article-title: Going from evidence to recommendations publication-title: BMJ – volume: 38 start-page: 19 year: 2008 end-page: 42 ident: bib6 article-title: BSACI guidelines for the management of allergic and non-allergic rhinitis publication-title: Clin Exp Allergy – volume: 63 start-page: 8 year: 2008 end-page: 160 ident: bib1 article-title: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) publication-title: Allergy – volume: 63 start-page: 990 year: 2008 end-page: 996 ident: bib19 article-title: Allergic rhinitis management pocket reference 2008 publication-title: Allergy – volume: 15 start-page: 58 year: 2006 end-page: 70 ident: bib5 article-title: International Primary Care Respiratory Group (IPCRG) guidelines: management of allergic rhinitis publication-title: Prim Care Respir J – volume: 58 start-page: 733 year: 2003 end-page: 741 ident: bib3 article-title: Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial publication-title: Allergy – volume: 374 start-page: 273 year: 2009 end-page: 275 ident: bib12 article-title: Clinical experts or methodologists to write clinical guidelines? publication-title: Lancet – volume: 63 start-page: 8 issue: suppl 86 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib1 article-title: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) publication-title: Allergy doi: 10.1111/j.1398-9995.2007.01620.x – volume: 58 start-page: 733 year: 2003 ident: 10.1016/j.jaci.2010.06.047_bib3 article-title: Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial publication-title: Allergy doi: 10.1034/j.1398-9995.2003.00076.x – volume: 108 start-page: S147 year: 2001 ident: 10.1016/j.jaci.2010.06.047_bib4 article-title: Allergic rhinitis and its impact on asthma publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.118891 – volume: 63 start-page: 990 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib19 article-title: Allergic rhinitis management pocket reference 2008 publication-title: Allergy doi: 10.1111/j.1398-9995.2008.01642.x – volume: 174 start-page: 605 year: 2006 ident: 10.1016/j.jaci.2010.06.047_bib8 article-title: An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200602-197ST – volume: 18 start-page: 250 year: 2009 ident: 10.1016/j.jaci.2010.06.047_bib13 article-title: Guidelines for allergic rhinitis need to be used in primary care publication-title: Prim Care Respir J doi: 10.4104/pcrj.2009.00028 – volume: 336 start-page: 995 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib15 article-title: What is “quality of evidence” and why is it important to clinicians? publication-title: BMJ doi: 10.1136/bmj.39490.551019.BE – volume: 336 start-page: 924 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib16 article-title: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations publication-title: BMJ doi: 10.1136/bmj.39489.470347.AD – volume: 122 start-page: S1 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib7 article-title: The diagnosis and management of rhinitis: an updated practice parameter publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2008.06.003 – volume: 4 start-page: 19 year: 2006 ident: 10.1016/j.jaci.2010.06.047_bib11 article-title: Improving the use of research evidence in guideline development: 7. Deciding what evidence to include publication-title: Health Res Policy Syst doi: 10.1186/1478-4505-4-19 – volume: 63 start-page: 38 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib9 article-title: Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update publication-title: Allergy doi: 10.1111/j.1398-9995.2007.01560.x – volume: 374 start-page: 273 year: 2009 ident: 10.1016/j.jaci.2010.06.047_bib12 article-title: Clinical experts or methodologists to write clinical guidelines? publication-title: Lancet doi: 10.1016/S0140-6736(09)60787-X – volume: 64 start-page: 123 year: 2009 ident: 10.1016/j.jaci.2010.06.047_bib2 article-title: Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three publication-title: Allergy doi: 10.1111/j.1398-9995.2008.01884.x – volume: 38 start-page: 19 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib6 article-title: BSACI guidelines for the management of allergic and non-allergic rhinitis publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2007.02888.x – volume: 4 start-page: 28 year: 2006 ident: 10.1016/j.jaci.2010.06.047_bib10 article-title: Improving the use of research evidence in guideline development: 16 publication-title: Evaluation. Health Res Policy Syst doi: 10.1186/1478-4505-4-28 – volume: 61 start-page: 1086 year: 2006 ident: 10.1016/j.jaci.2010.06.047_bib21 article-title: Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN) publication-title: Allergy doi: 10.1111/j.1398-9995.2006.01144.x – volume: 15 start-page: 58 year: 2006 ident: 10.1016/j.jaci.2010.06.047_bib5 article-title: International Primary Care Respiratory Group (IPCRG) guidelines: management of allergic rhinitis publication-title: Prim Care Respir J doi: 10.1016/j.pcrj.2005.11.002 – volume: 336 start-page: 1049 year: 2008 ident: 10.1016/j.jaci.2010.06.047_bib14 article-title: Going from evidence to recommendations publication-title: BMJ doi: 10.1136/bmj.39493.646875.AE – volume: 64 start-page: 669 year: 2009 ident: 10.1016/j.jaci.2010.06.047_bib17 article-title: Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions publication-title: Allergy doi: 10.1111/j.1398-9995.2009.01973.x – volume: 59 start-page: 373 year: 2004 ident: 10.1016/j.jaci.2010.06.047_bib18 article-title: ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma publication-title: Allergy doi: 10.1111/j.1398-9995.2003.00468.x – volume: 65 start-page: 459 year: 2010 ident: 10.1016/j.jaci.2010.06.047_bib20 article-title: Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper publication-title: Allergy doi: 10.1111/j.1398-9995.2009.02325.x – reference: 21496893 - J Allergy Clin Immunol. 2011 Jun;127(6):1641-2; author reply 1643-5. doi: 10.1016/j.jaci.2011.01.071. – reference: 21481444 - J Allergy Clin Immunol. 2011 Jun;127(6):1640-1.e1; author reply 1643-5. doi: 10.1016/j.jaci.2011.01.070. |
| SSID | ssj0009389 |
| Score | 2.5804157 |
| Snippet | Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines... Background Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA)... Background: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA)... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 466 |
| SubjectTerms | Adult Allergies Allergy and Immunology Asthma - drug therapy Asthma - prevention & control Asthma - therapy Biological and medical sciences Child Child, Preschool Children & youth Colleges & universities Desensitization, Immunologic - standards Female Fundamental and applied biological sciences. Psychology Fundamental immunology Guidelines as Topic - standards Hospitals Humans Immunopathology Infant Infant, Newborn Medical sciences Non tumoral diseases Otolaryngology Otorhinolaryngology. Stomatology practice guideline Pregnancy Rhinitis, Allergic, Perennial - drug therapy Rhinitis, Allergic, Perennial - prevention & control Rhinitis, Allergic, Perennial - therapy Rhinitis, Allergic, Seasonal - drug therapy Rhinitis, Allergic, Seasonal - prevention & control Rhinitis, Allergic, Seasonal - therapy Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Tobacco Smoke Pollution - adverse effects Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology |
| Title | Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674910010572 https://www.clinicalkey.es/playcontent/1-s2.0-S0091674910010572 https://dx.doi.org/10.1016/j.jaci.2010.06.047 https://www.ncbi.nlm.nih.gov/pubmed/20816182 https://www.proquest.com/docview/1505300512 https://www.proquest.com/docview/754016080 https://www.proquest.com/docview/817604653 |
| Volume | 126 |
| WOSCitedRecordID | wos000281512500008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect customDbUrl: eissn: 1097-6825 dateEnd: 20200131 omitProxy: false ssIdentifier: ssj0009389 issn: 0091-6749 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rb9MwELfKhhASQrwpjMofmASqUsV52A7fuqqI8pgQG1K_WW7idC0lrZZ22l_D38pdnaTtSsdD4ktUxXHPyf3su7PvQchLEFqBl8IE1JE3cALmpY4MPeMIL0kZoChNuF4WmxDHx7Lfjz7Xaj_KWJiLicgyeXkZzf4rq-EeMBtDZ_-C3dWfwg34DUyHK7Adrn_E-DYG9w3RP_5shJ5BeXU-0CsiIjNgyvzsu0btsv2l18adgeEC812hDzzuEeDh9fLYIC_Ztq2_6iUdm76piq8cYbjJxk492PmHnfDwqGO-Wa_crPmxVTVOFzkIJnseYlZAPdIm005HDzNbcgr9UibTvNld65mNbNMJvu10ffcCD96j9d2LKqxmw-sT9D7mcGFzmVbLtI2sL_Dory26Aedr8juw9WS2RIPdpRi3xjoeFS59vOXadJ9XUm6f4ACQPlsWEBUg4vc9EUawau63e93--1VaZ19aA6sYcBGWZT0Ir1LapfrcmekcWJTaSiq7TZ2lynN6j9wteE3bFmP3Sc1kD8itT4U3xkPyoYQaLaFGAQwUoEYt1Og0oxZq9BUC7TVdwewNxTHTEmSPyNe33dPOO6cozuHEoPTOHa5lkAx4xIVxB0ESyCTFVEbhIAgjN01dzePYaB7CxNdGyNgfMNB8jR9rV2pQkv3HZC-bZuYpoRqbQM4xLHUAKqQ2QcoZ92QivBTs4Tph5XdTcZG5HguoTFTpojhW-K0Vjluhn2Yg6qRZ9ZnZvC3XPu2X7FDljAEZqgA71_YSv-pl8mI1yBVTuadctYWnOgmrnoWmazXY31JsbGClejWwiwCJXNbJQQketRoFWDlYlYIBXVo1gxjBs0GdGZjqSoDlxjiYj7sfkUxwF9Mx1skTC8sVeSzfw6T37J--43Nye7U0HJC9-fnCvCA34wvA7XmD3BB92Sgm3k9QFPpF |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Allergic+Rhinitis+and+its+Impact+on+Asthma+%28ARIA%29+guidelines%3A+2010+Revision&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Bro%C5%BCek%2C+Jan+L.&rft.au=Bousquet%2C+Jean&rft.au=Baena-Cagnani%2C+Carlos+E.&rft.au=Bonini%2C+Sergio&rft.date=2010-09-01&rft.pub=Elsevier+Inc&rft.issn=0091-6749&rft.volume=126&rft.issue=3&rft.spage=466&rft.epage=476&rft_id=info:doi/10.1016%2Fj.jaci.2010.06.047&rft.externalDocID=S0091674910010572 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674910X00112%2Fcov150h.gif |